Skip to main content

Table 2 Family physicians who prescribe each drug at different times and mean prescriptions per physician

From: Adoption of new drugs by physicians: a survival analysis

  Month since launching          
  2 3 6 12 24 36
  n Mean (SD) n Mean (SD) n Mean (SD) n Mean (SD) n Mean (SD) n Mean (SD)
Cefditoren 7 3.6 (4.2) 26 2.3 (1.9) 30 3.4 (2.8) 32 3.3 (5.7) 44 2.0 (2.2) 51 2.6 (2.8)
Duloxetine 38 1.5 (0.9) 67 2.0 (1.5) 125 2.4 (2.0) 172 3.5 (2.7) 176 5.1 (3.8) * *
Etoricoxib 14 1.1 (0.4) 32 1.6 (0.9) 41 1.4 (0.6) 44 1.5 (0.8) 48 1.9 (1.3) 124 3.1 (4.0)
Ezetimibe 31 2.0 (1.4) 59 2.0 (1.5) 94 2.3 (1.9) 148 2.7 (2.5) 200 4.0 (3.6) 191 4.6 (3.8)
Levocetirizine 8 1.6 (0.9) 9 1.6 (0.7) 21 1.2 (0.4) 75 2.2 (1.6) 132 2.4 (1.7) 158 3.0 (2.8)
Olmesartan 36 1.8 (1.0) 49 2.2 (1.3) 89 2.3 (1.7) 131 3.4 (3.7) 165 4.1 (4.8) 182 4.7 (5.5)
Pregabalin 14 1.3 (0.5) 31 1.7 (1.4) 80 1.8 (1.0) 137 2.3 (1.8) 181 3.7 (2.7) 198 5.1 (3.6)
Tiotropium 80 2.3 (1.6) 127 2.9 (2.4) 215 3.5 (2.6) 244 5.9 (4.0) 264 7.4 (4.9) 264 8.5 (5.4)
  1. n number of physicians. SD standard deviation.
  2. *Data of 36th month of duloxetine are no comparable due to changes in medical staff.